v3.25.1
INVESTMENTS AND FAIR VALUE DISCLOSURES - Schedule of Assets and Liabilities Measured at Fair Value (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Preferred equity investment, at fair value $ 268,263 $ 267,169
Equity investments in the Company’s products 73,276 96,956
CLOs 7,702 5,169
TRA liability 97,228 108,257
Earnout liability 306,206 168,441
Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Preferred equity investment, at fair value 268,263 267,169
Equity investments in the Company’s products 73,276 96,956
CLOs 7,702 5,169
Total Assets, at Fair Value 349,241 369,294
TRA liability 97,228 108,257
Earnout liability 306,206 168,441
Total Liabilities, at Fair Value 403,434 276,698
Fair Value, Recurring | Level I    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Preferred equity investment, at fair value 0 0
Equity investments in the Company’s products 0 0
CLOs 0 0
Total Assets, at Fair Value 0 0
TRA liability 0 0
Earnout liability 0 0
Total Liabilities, at Fair Value 0 0
Fair Value, Recurring | Level II    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Preferred equity investment, at fair value 0 0
Equity investments in the Company’s products 73,276 96,956
CLOs 0 0
Total Assets, at Fair Value 73,276 96,956
TRA liability 0 0
Earnout liability 526 529
Total Liabilities, at Fair Value 526 529
Fair Value, Recurring | Level III    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Preferred equity investment, at fair value 268,263 267,169
Equity investments in the Company’s products 0 0
CLOs 7,702 5,169
Total Assets, at Fair Value 275,965 272,338
TRA liability 97,228 108,257
Earnout liability 305,680 167,912
Total Liabilities, at Fair Value $ 402,908 $ 276,169